¹«Á» : ½ÃÀå ÀλçÀÌÆ®, ¿ªÇÐ ¹× ½ÃÀå ¿¹Ãø(-2034³â)
Tinea Pedis - Market Insight, Epidemiology, and Market Forecast - 2034
»óǰÄÚµå : 1506263
¸®¼­Ä¡»ç : DelveInsight Business Research LLP
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 7,950 £Ü 11,281,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 11,925 £Ü 16,922,000
PDF (2-3 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 3¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 15,900 £Ü 22,563,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 23,850 £Ü 33,845,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀÌ º¸°í¼­´Â ¼¼°è ÁÖ¿ä 7°³±¹ÀÇ ¹«Á» ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ÁúȯÀÇ ¹è°æ ¹× °³¿ä, ¿ªÇÐ, Ä¡·á ¹× °ü¸® °³¿ä, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× À庮, ¹ÌÃæÁ· ¼ö¿ä, ½ÃÆÇ ÁßÀÎ ÀǾàǰ ¹× ÆÄÀÌÇÁ¶óÀÎ ÀǾàǰ ÇÁ·ÎÆÄÀÏ, ÁÖ¿ä ±¹°¡º° ½ÃÀå ±Ô¸ð ÃßÀÌ ¹× ¿¹Ãø, °æÀï ±¸µµ µîÀ» Á¤¸®ÇÏ¿© ÃÖÀûÀÇ ±âȸ¸¦ ¹ß±¼ÇÏ°í ½ÃÀåÀÇ ÀáÀç·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

´ë»ó Áö¿ª

Á¶»ç ±â°£ : 2020-2034³â

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ÀλçÀÌÆ®

Á¦2Àå ¹«Á» : ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹«Á» : °æÀï Á¤º¸ ºÐ¼®

Á¦4Àå ¹«Á» : ½ÃÀå °³¿ä

Á¦5Àå ¹«Á» : ÁúȯÀÇ ¹è°æ°ú °³¿ä

Á¦6Àå ȯÀÚ ¿©Á¤

Á¦7Àå ¹«Á» : ¿ªÇÐ ¹× ȯÀÚ Àα¸

Á¦8Àå Ä¡·á ¾Ë°í¸®Áò, ÇöÀçÀÇ Ä¡·á ¹× ÀÇ·á ÇàÀ§

Á¦9Àå ¹ÌÃæÁ· ¿ä±¸

Á¦10Àå ¹«Á» Ä¡·áÀÇ ÁÖ¿ä ¿£µåÆ÷ÀÎÆ®

Á¦11Àå Ãâ½Ã Á¦Ç°

Á¦12Àå »õ·Î¿î Ä¡·á¹ý

Á¦13Àå ¹«Á» : ÁÖ¿ä 7°³±¹ ½ÃÀå ºÐ¼®

Á¦14Àå ¼Ó¼º ºÐ¼®

Á¦15Àå ÁÖ¿ä 7°³±¹ : ½ÃÀå Àü¸Á

Á¦16Àå ¹«Á» : Á¢±Ù ¹× »óȯ °³¿ä

Á¦17Àå KOL(Key Opinion Leader)ÀÇ °ßÇØ

Á¦18Àå ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

Á¦19Àå ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¦20Àå ºÎ·Ï

Á¦21Àå DelveInsightÀÇ ¼­ºñ½º ³»¿ë

Á¦22Àå ¸éÃ¥»çÇ×

Á¦23Àå DelveInsight¿¡ ´ëÇØ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

DelveInsight's "Tinea Pedis - Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Tinea Pedis, historical and forecasted epidemiology as well as the Tinea Pedis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Tinea Pedis market report provides current treatment practices, emerging drugs, Tinea Pedis market share of the individual therapies, current and forecasted Tinea Pedis market size from 2020 to 2034 segmented by seven major markets. The Report also covers current Tinea Pedis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Geography Covered:

Study Period: 2020-2034

Tinea Pedis Disease Understanding and Treatment Algorithm

The DelveInsight Tinea Pedis market report gives a thorough understanding of the Tinea Pedis by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Tinea Pedis.

Treatment

It covers the details of conventional and current medical therapies available in the Tinea Pedis market for the treatment of the condition. It also provides Tinea Pedis treatment algorithms and guidelines in the United States, Europe, and Japan.

Tinea Pedis Epidemiology

The Tinea Pedis epidemiology division provide insights about historical and current Tinea Pedis patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Tinea Pedis epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2020 to 2034.

Country Wise-Tinea Pedis Epidemiology

The epidemiology segment also provides the Tinea Pedis epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Tinea Pedis Drug Chapters

Drug chapter segment of the Tinea Pedis report encloses the detailed analysis of Tinea Pedis marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Tinea Pedis clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Marketed Drugs

The report provides the details of the marketed product available for Tinea Pedis treatment.

Tinea Pedis Emerging Drugs

The report provides the details of the emerging therapies under the late and mid-stage of development for Tinea Pedis treatment.

Tinea Pedis Market Outlook

The Tinea Pedis market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Tinea Pedis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a thorough detail of Tinea Pedis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, Tinea Pedis market in 7MM is expected to change in the study period 2020-2034.

Key Findings

This section includes a glimpse of the Tinea Pedis market in 7MM.

The United States Market Outlook

This section provides the total Tinea Pedis market size and market size by therapies in the United States.

EU-5 Countries: Market Outlook

The total Tinea Pedis market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Market Outlook

The total Tinea Pedis market size and market size by therapies in Japan is also mentioned.

Tinea Pedis Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the Tinea Pedis market or expected to get launched in the market during the study period 2020-2034. The analysis covers Tinea Pedis market uptake by drugs; patient uptake by therapies; and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Tinea Pedis Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Tinea Pedis key players involved in developing targeted therapeutics.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Tinea Pedis emerging therapies.

Reimbursement Scenario in Tinea Pedis

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current market trends, we take KOLs and SME's opinion working in Tinea Pedis domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Tinea Pedis market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Tinea Pedis Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report:

Report Highlights:

Tinea Pedis Report Insights

Tinea Pedis Report Key Strengths

Tinea Pedis Report Assessment

Key Questions:

Market Insights:

Epidemiology Insights:

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

Reasons to buy:

Table of Contents

1. Key Insights

2. Executive Summary of Tinea Pedis

3. Competitive Intelligence Analysis for Tinea Pedis

4. Tinea Pedis: Market Overview at a Glance

5. Tinea Pedis: Disease Background and Overview

6. Patient Journey

7. Tinea Pedis Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Tinea Pedis Treatment

11. Marketed Products

List to be continued in report

12. Emerging Therapies

List to be continued in report

13. Tinea Pedis: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Tinea Pedis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

The table of contents is not exhaustive; the final content may vary.

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â